ID   TET_PYRHO               Reviewed;         353 AA.
AC   O59196;
DT   09-FEB-2010, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 1.
DT   22-JUL-2015, entry version 80.
DE   RecName: Full=Tetrahedral aminopeptidase;
DE            Short=TET;
DE            Short=TET aminopeptidase;
DE            EC=3.4.11.-;
DE   AltName: Full=Leucyl aminopeptidase;
DE   AltName: Full=PhTET2;
GN   Name=frvX; OrderedLocusNames=PH1527;
OS   Pyrococcus horikoshii (strain ATCC 700860 / DSM 12428 / JCM 9974 /
OS   NBRC 100139 / OT-3).
OC   Archaea; Euryarchaeota; Thermococci; Thermococcales; Thermococcaceae;
OC   Pyrococcus.
OX   NCBI_TaxID=70601;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 700860 / DSM 12428 / JCM 9974 / NBRC 100139 / OT-3;
RX   PubMed=9679194; DOI=10.1093/dnares/5.2.55;
RA   Kawarabayasi Y., Sawada M., Horikawa H., Haikawa Y., Hino Y.,
RA   Yamamoto S., Sekine M., Baba S., Kosugi H., Hosoyama A., Nagai Y.,
RA   Sakai M., Ogura K., Otsuka R., Nakazawa H., Takamiya M., Ohfuku Y.,
RA   Funahashi T., Tanaka T., Kudoh Y., Yamazaki J., Kushida N., Oguchi A.,
RA   Aoki K., Yoshizawa T., Nakamura Y., Robb F.T., Horikoshi K.,
RA   Masuchi Y., Shizuya H., Kikuchi H.;
RT   "Complete sequence and gene organization of the genome of a hyper-
RT   thermophilic archaebacterium, Pyrococcus horikoshii OT3.";
RL   DNA Res. 5:55-76(1998).
RN   [2]
RP   FUNCTION AS AN AMINOPEPTIDASE, CATALYTIC ACTIVITY, COFACTOR, SUBSTRATE
RP   SPECIFICITY, ENZYME REGULATION, BIOPHYSICOCHEMICAL PROPERTIES,
RP   SUBUNIT, AND REACTION MECHANISM.
RX   PubMed=15736957; DOI=10.1021/bi047736j;
RA   Dura M.A., Receveur-Brechot V., Andrieu J.P., Ebel C., Schoehn G.,
RA   Roussel A., Franzetti B.;
RT   "Characterization of a TET-like aminopeptidase complex from the
RT   hyperthermophilic archaeon Pyrococcus horikoshii.";
RL   Biochemistry 44:3477-3486(2005).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (1.96 ANGSTROMS) IN COMPLEX WITH ZINC IONS,
RP   FUNCTION AS AN AMINOPEPTIDASE, CATALYTIC ACTIVITY, COFACTOR, SUBUNIT,
RP   ACTIVE SITE, AND CATALYTIC MECHANISM.
RX   PubMed=15375159; DOI=10.1074/jbc.M409455200;
RA   Russo S., Baumann U.;
RT   "Crystal structure of a dodecameric tetrahedral-shaped
RT   aminopeptidase.";
RL   J. Biol. Chem. 279:51275-51281(2004).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) IN COMPLEXES WITH ZINC IONS AND
RP   THE INHIBITOR AMASTATIN, FUNCTION IN PROTEIN DEGRADATION, COFACTOR,
RP   SUBUNIT, ACTIVE SITE, AND CATALYTIC MECHANISM.
RX   PubMed=15713475; DOI=10.1016/j.jmb.2004.12.056;
RA   Borissenko L., Groll M.;
RT   "Crystal structure of TET protease reveals complementary protein
RT   degradation pathways in prokaryotes.";
RL   J. Mol. Biol. 346:1207-1219(2005).
CC   -!- FUNCTION: Functions as an aminopeptidase, with a clear preference
CC       for leucine as the N-terminal amino acid. However, can also cleave
CC       moderately long polypeptide substrates of various compositions in
CC       a fairly unspecific manner. Has neither carboxypeptidase nor
CC       endoproteolytic activities, and it is devoid of N-terminal
CC       deblocking activity. Is involved in protein degradation,
CC       performing degradation of oligopeptides produced by the proteasome
CC       into single amino acids. {ECO:0000269|PubMed:15375159,
CC       ECO:0000269|PubMed:15713475, ECO:0000269|PubMed:15736957}.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000269|PubMed:15375159,
CC         ECO:0000269|PubMed:15713475, ECO:0000269|PubMed:15736957};
CC       Name=Co(2+); Xref=ChEBI:CHEBI:48828;
CC         Evidence={ECO:0000269|PubMed:15375159,
CC         ECO:0000269|PubMed:15713475, ECO:0000269|PubMed:15736957};
CC       Note=Binds 2 Zn(2+) ions per subunit. Can also use Co(2+).
CC       {ECO:0000269|PubMed:15375159, ECO:0000269|PubMed:15713475,
CC       ECO:0000269|PubMed:15736957};
CC   -!- ENZYME REGULATION: Inhibited by EDTA and bestatin in vitro. Is
CC       insensitive to papain, antipain, chymostatin, leupeptin, pepstatin
CC       and aprotinin. {ECO:0000269|PubMed:15736957}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Optimum pH is 7.5 with Leu-pNA as substrate. Strong activity is
CC         still detectable at pH 6 and 9. {ECO:0000269|PubMed:15736957};
CC       Temperature dependence:
CC         Optimum temperature is 100 degrees Celsius over a broad pH
CC         array. At temperatures lower than 70 degrees Celsius, less than
CC         10% of the maximum activity is detected. Highly thermostable.
CC         Shows half-lives of 24.8 minutes and 10.03 hours when incubated
CC         at 100 and 80 degrees Celsius, respectively.
CC         {ECO:0000269|PubMed:15736957};
CC   -!- SUBUNIT: Homododecamer. The assembly of six dimers results in a
CC       tetrahedral-shaped structure; all 12 active sites are located on
CC       the inside of the tetrahedron. Substrate access is granted by four
CC       pores with a maximal diameter of 18 Angstroms, allowing only small
CC       peptides and unfolded proteins access to the active site. Beside
CC       the four entry ports, TET contains 12 small product release
CC       openings, which are large enough to allow passage of only single
CC       amino acid residues. {ECO:0000269|PubMed:15375159,
CC       ECO:0000269|PubMed:15713475, ECO:0000269|PubMed:15736957}.
CC   -!- MISCELLANEOUS: The hydrolytic mechanism is nonprocessive.
CC       Therefore, the enzyme does not process one substrate molecule
CC       completely before starting with another one. Instead, the reaction
CC       products are generated by multiple rounds of substrate digestion.
CC   -!- SIMILARITY: Belongs to the peptidase M42 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BA000001; BAA30637.1; -; Genomic_DNA.
DR   PIR; E71029; E71029.
DR   RefSeq; NP_143387.1; NC_000961.1.
DR   RefSeq; WP_010885603.1; NC_000961.1.
DR   PDB; 1XFO; X-ray; 1.96 A; A/B/C/D=1-353.
DR   PDB; 1Y0R; X-ray; 1.75 A; A=1-353.
DR   PDB; 1Y0Y; X-ray; 1.60 A; A=1-353.
DR   PDBsum; 1XFO; -.
DR   PDBsum; 1Y0R; -.
DR   PDBsum; 1Y0Y; -.
DR   ProteinModelPortal; O59196; -.
DR   SMR; O59196; 1-353.
DR   STRING; 70601.PH1527; -.
DR   MEROPS; M42.004; -.
DR   EnsemblBacteria; BAA30637; BAA30637; BAA30637.
DR   GeneID; 1443843; -.
DR   KEGG; pho:PH1527; -.
DR   eggNOG; COG1363; -.
DR   HOGENOM; HOG000291972; -.
DR   KO; K01179; -.
DR   OMA; ICHPTIV; -.
DR   BioCyc; PHOR70601:GJWR-1528-MONOMER; -.
DR   BRENDA; 3.4.11.1; 5244.
DR   BRENDA; 3.4.11.B4; 5244.
DR   EvolutionaryTrace; O59196; -.
DR   Proteomes; UP000000752; Chromosome.
DR   GO; GO:0004177; F:aminopeptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0008237; F:metallopeptidase activity; IEA:UniProtKB-KW.
DR   Gene3D; 2.40.30.40; -; 1.
DR   InterPro; IPR008007; Peptidase_M42.
DR   InterPro; IPR023367; Peptidase_M42_dom2.
DR   Pfam; PF05343; Peptidase_M42; 1.
DR   PIRSF; PIRSF001123; PepA_GA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Aminopeptidase; Cobalt; Complete proteome; Hydrolase;
KW   Metal-binding; Metalloprotease; Protease; Zinc.
FT   CHAIN         1    353       Tetrahedral aminopeptidase.
FT                                /FTId=PRO_0000391012.
FT   ACT_SITE    212    212       Proton acceptor.
FT                                {ECO:0000269|PubMed:15375159,
FT                                ECO:0000269|PubMed:15713475}.
FT   METAL        68     68       Zinc 1.
FT   METAL       182    182       Zinc 1.
FT   METAL       182    182       Zinc 2.
FT   METAL       213    213       Zinc 2.
FT   METAL       235    235       Zinc 1.
FT   METAL       323    323       Zinc 2.
FT   HELIX         9     17       {ECO:0000244|PDB:1Y0Y}.
FT   HELIX        25     27       {ECO:0000244|PDB:1Y0Y}.
FT   HELIX        29     37       {ECO:0000244|PDB:1Y0Y}.
FT   HELIX        38     40       {ECO:0000244|PDB:1Y0Y}.
FT   STRAND       41     46       {ECO:0000244|PDB:1Y0Y}.
FT   STRAND       52     56       {ECO:0000244|PDB:1Y0Y}.
FT   STRAND       62     68       {ECO:0000244|PDB:1Y0Y}.
FT   STRAND       73     79       {ECO:0000244|PDB:1Y0Y}.
FT   STRAND       85     92       {ECO:0000244|PDB:1Y0Y}.
FT   HELIX        95     97       {ECO:0000244|PDB:1Y0Y}.
FT   TURN         98    100       {ECO:0000244|PDB:1Y0Y}.
FT   STRAND      102    108       {ECO:0000244|PDB:1Y0Y}.
FT   STRAND      111    118       {ECO:0000244|PDB:1Y0Y}.
FT   HELIX       136    138       {ECO:0000244|PDB:1Y0Y}.
FT   STRAND      140    142       {ECO:0000244|PDB:1Y0Y}.
FT   HELIX       148    153       {ECO:0000244|PDB:1Y0Y}.
FT   STRAND      161    164       {ECO:0000244|PDB:1Y0Y}.
FT   STRAND      169    171       {ECO:0000244|PDB:1Y0Y}.
FT   TURN        172    174       {ECO:0000244|PDB:1Y0Y}.
FT   STRAND      175    178       {ECO:0000244|PDB:1Y0Y}.
FT   HELIX       181    196       {ECO:0000244|PDB:1Y0Y}.
FT   STRAND      201    210       {ECO:0000244|PDB:1Y0Y}.
FT   TURN        213    215       {ECO:0000244|PDB:1Y0Y}.
FT   HELIX       217    226       {ECO:0000244|PDB:1Y0Y}.
FT   STRAND      229    238       {ECO:0000244|PDB:1Y0Y}.
FT   HELIX       247    249       {ECO:0000244|PDB:1Y0Y}.
FT   STRAND      258    264       {ECO:0000244|PDB:1Y0Y}.
FT   HELIX       271    283       {ECO:0000244|PDB:1Y0Y}.
FT   STRAND      288    292       {ECO:0000244|PDB:1Y0Y}.
FT   HELIX       300    303       {ECO:0000244|PDB:1Y0Y}.
FT   STRAND      312    321       {ECO:0000244|PDB:1Y0Y}.
FT   STRAND      323    325       {ECO:0000244|PDB:1Y0Y}.
FT   STRAND      327    330       {ECO:0000244|PDB:1Y0Y}.
FT   HELIX       331    347       {ECO:0000244|PDB:1Y0Y}.
FT   HELIX       348    350       {ECO:0000244|PDB:1Y0Y}.
SQ   SEQUENCE   353 AA;  39014 MW;  A6AE25809C8B2041 CRC64;
     MEVRNMVDYE LLKKVVEAPG VSGYEFLGIR DVVIEEIKDY VDEVKVDKLG NVIAHKKGEG
     PKVMIAAHMD QIGLMVTHIE KNGFLRVAPI GGVDPKTLIA QRFKVWIDKG KFIYGVGASV
     PPHIQKPEDR KKAPDWDQIF IDIGAESKEE AEDMGVKIGT VITWDGRLER LGKHRFVSIA
     FDDRIAVYTI LEVAKQLKDA KADVYFVATV QEEVGLRGAR TSAFGIEPDY GFAIDVTIAA
     DIPGTPEHKQ VTHLGKGTAI KIMDRSVICH PTIVRWLEEL AKKHEIPYQL EILLGGGTDA
     GAIHLTKAGV PTGALSVPAR YIHSNTEVVD ERDVDATVEL MTKALENIHE LKI
//
